🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The ISST study investigates whether integrated social cognitive remediation...
Status
Completed
Location
Rheinhessen-Fachklinik Alzey
Start Date
2016-03
Trial ID
NCT02678858
Treatments Being Tested
The goal of this clinical trial is to determine if a complex intervention c...
Status
Completed
Location
The George Institute for Global Health
Start Date
2022-06-06
Trial ID
NCT05752955
Treatments Being Tested
To compare the relative bioavailability of gabapentin 400 mg capsules (Pure...
Status
Completed
Location
Gateway Medical Research, Inc
Start Date
1998-01
Trial ID
NCT00864058
Treatments Being Tested
This is a randomized placebo/sham controlled, double-blind study investigat...
Status
Terminated
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02369614
Treatments Being Tested
Atomoxetine (Strattera) is a drug that is currently approved for treatment ...
Status
Completed
Location
Johns Hopkins Hospital
Start Date
2005-01-06
Trial ID
NCT00286949
Treatments Being Tested
Celiac disease (CD) is an immunological disorder that mainly affects the sm...
Status
Completed
Location
University of Alicante
Start Date
2018-09-01
Trial ID
NCT05052164
Unbranded drug molecules are produced after the patent of a given drug has ...
Status
Completed
Location
Fundación Universitaria de Ciencias de la Salud, Hospital de San Jose
Start Date
2012-10
Trial ID
NCT02048293
Treatments Being Tested
This phase will commence following dose escalation in the 24mg bid group du...
Status
Recruiting
Location
The First Affilliated Hospital of Bengbu Medical University
Start Date
2025-01-28
Trial ID
NCT06754891
Treatments Being Tested
Many studies have been conducted to identify therapeutic strategies to modu...
Status
Completed
Location
Denise Mafra
Start Date
2018-02-22
Trial ID
NCT03475017
Treatments Being Tested